Tag - TMTA

Transmeta Corp. (Nasdaq:TMTA) is the sole 52-week high on Monday's session.

Small-cap stocks turned in their best performance of the New Year today, as investors decided that a dreary picture of the current economic environment would simply make it that much easier for incoming President-elect Obama to push through a big fiscal stimulus package. Some of today’s small-cap gainers are Michael Baker Corporation (NYSE:BKR), Repros Therapeutics (Nasdaq:RPRX) and China Sky One Medical (Nasdaq:CSKI).

Other Market Watch highlights today included:

• Advancers are leading decliners on the Russell 2000 by more than three to one.
• Worst performers: food retailers, brewers, chemical companies, finance firms, biotechs and footwear firms.  
• Homebuilder, energy and retailer stocks were solid performers so far today, and surprisingly, airline stocks were doing well despite a rise to five-week highs in crude oil prices.  
• Small-cap stocks remained higher into midday trading.  

Other Market Watch highlights today included:

• Worst performers: food retailers, brewers, chemical companies, finance firms, biotechs and footwear firms.  
• Homebuilder, energy and retailer stocks were solid performers so far today, and surprisingly, airline stocks were doing well despite a rise to five-week highs in crude oil prices.  
• Small-cap stocks remained higher into midday trading.  
• Advancers are leading decliners on the Russell 2000 by 1,402 to 372. 
 

Small Cap Gainers:

• New 52-wk highs: Michael Baker Corporation, Repros Therapeutics, China Sky One Medical, Transmeta Corporation and Amerisafe, Inc. (See NYSE:BKR, Nasdaq:RPRX, Nasdaq:CSKI, Nasdaq:TMTA, Nasdaq:AMSF)  
• Home-nursing company Amedisys Inc. is up 16.4% to $46.93 after issuing FY09 guidance above concensus. (See Nasdaq:AMED)  

Small Cap Losers:

• LSI Industries is down 14% to $6.03 after lowering FY09 earnings and sales guidance below consensus. (See Nasdaq:LYTS)  
• VASCO Data Security International Inc. is 12% lower at $9.10 in pre-market trading after issuing downward guidance for FY2008. (See Nasdaq:VDSI) 
• Vignette Corporation is down 8.8% to $8.24 after issuing preliminary Q4 2008 results late Monday. (See Nasdaq:VIGN) 

Repros Therapeutics Inc. (Nasdaq:RPRX), China Sky One Medical Inc. (Nasdaq:CSKI) and Orchids Paper Products Co. (Nasdaq:TIS) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: VSE Corp. (Nasdaq:VSEC), Maxygen Inc. (Nasdaq:MAXY), American Italian Pasta Co. (Nasdaq:AIPC), Transmeta Corp. (Nasdaq:TMTA), Michael Baker Corp. (Nasdaq:BKR) and Answers Corp. (Nasdaq:ANSW).

Small-cap stocks remained higher into midday trading, surviving a choppy response to economic data this morning that served up better-than-expected numbers on services sector activity, but slumping factory orders and sinking pending home sales. Some of today’s small-cap gainers are Michael Baker Corporation (NYSE:BKR), Repros Therapeutics (Nasdaq:RPRX) and China Sky One Medical (Nasdaq:CSKI).

Other Market Watch highlights today included:

• Worst performers: food retailers, brewers, chemical companies, finance firms, biotechs and footwear firms.  
• Homebuilder, energy and retailer stocks were solid performers so far today, and surprisingly, airline stocks were doing well despite a rise to five-week highs in crude oil prices.  
• Small-cap stocks remained higher into midday trading.  
• Advancers are leading decliners on the Russell 2000 by 1,402 to 372. 
 

Small Cap Gainers:

• New 52-wk highs: Michael Baker Corporation, Repros Therapeutics, China Sky One Medical, Transmeta Corporation and Amerisafe, Inc. (See NYSE:BKR, Nasdaq:RPRX, Nasdaq:CSKI, Nasdaq:TMTA, Nasdaq:AMSF)  
• Home-nursing company Amedisys Inc. is up 16.4% to $46.93 after issuing FY09 guidance above concensus. (See Nasdaq:AMED)  

Small Cap Losers:

• LSI Industries is down 14% to $6.03 after lowering FY09 earnings and sales guidance below consensus. (See Nasdaq:LYTS)  
• VASCO Data Security International Inc. is 12% lower at $9.10 in pre-market trading after issuing downward guidance for FY2008. (See Nasdaq:VDSI) 
• Vignette Corporation is down 8.8% to $8.24 after issuing preliminary Q4 2008 results late Monday. (See Nasdaq:VIGN)  

Small-cap stocks pulled higher this morning and remained in positive ground after a mixed batch of economic reports buffeted the market. A firm tone in energy stocks, momentum from overseas gains and optimism about upcoming stimulus plans provided a lift. Some of today’s small-cap gainers are Michael Baker Corporation (NYSE:BKR), Repros Therapeutics (Nasdaq:RPRX) and China Sky One Medical (Nasdaq:CSKI).

Other Market Watch highlights today included:

• Advancers are leading decliners on the Russell 2000 by 1,402 to 372.  
• Looking at the chart picture for small-caps, the market remains in an upward consolidation mode.  
• Pending home sales were also sour, sinking 4.0% versus the consensus for a decline of 1.0%.  
• Factory orders tumbled 4.6%, much worse than the projection for a decline of 2.5%.  
• The ISM Non-Manufacturing Survey came in at 40.6, which was better than the forecast of 37.0 and a nice bounce off record lows from the previous reading.  

Small Cap Gainers:

• New 52-wk highs: Michael Baker Corporation, Repros Therapeutics, China Sky One Medical, Transmeta Corporation and Amerisafe, Inc. (See NYSE:BKR, Nasdaq:RPRX, Nasdaq:CSKI, Nasdaq:TMTA, Nasdaq:AMSF)  
• Home-nursing company Amedisys Inc. is up 16.4% to $46.93 after issuing FY09 guidance above concensus. (See Nasdaq:AMED)  

Small Cap Losers:

• LSI Industries is down 14% to $6.03 after lowering FY09 earnings and sales guidance below consensus. (See Nasdaq:LYTS)  
• VASCO Data Security International Inc. is 12% lower at $9.10 in pre-market trading after issuing downward guidance for FY2008. (See Nasdaq:VDSI) 
• Vignette Corporation is down 8.8% to $8.24 after issuing preliminary Q4 2008 results late Monday. (See Nasdaq:VIGN)  

Transmeta Corp. (Nasdaq:TMTA), DryShips Inc. (Nasdaq:DRYS) and SuccessFactors Inc. (Nasdaq:SFSF) are among the most actively traded companies in Wednesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Altra Holdings Inc. (Nasdaq:AIMC), IPG Photonics Corp. (Nasdaq:IPGP), Mentor Graphics Corp. (Nasdaq:MENT), Canadian Solar Inc. (Nasdaq:CSIQ), James River Coal Co. (Nasdaq:JRCC) and True Religion Apparel Inc. (Nasdaq:TRLG).

CastlePoint Holdings Ltd. (Nasdaq:CPHL), DivX Inc. (Nasdaq:DIVX) and DryShips Inc. (Nasdaq:DRYS) are among the most actively traded companies in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Given Imaging Ltd. (Nasdaq:GIVN), Sigma Designs Inc. (Nasdaq:SIGM), Central European Media Enterprises Ltd. (Nasdaq:CETV), TBS International Ltd. (Nasdaq:TBSI), Transmeta Corp (Nasdaq:TMTA) and Canadian Solar Inc. (Nasdaq:CSIQ).

Transmeta Corp. (Nasdaq:TMTA), PetMed Express Inc. (Nasdaq:PETS) and Union Street Acquisition Units (Nasdaq:USQ.U) are among the new 52-week highs in Thursday's trading among companies with market capitalizations under $1 billion.

Small-cap stocks pushed higher Thursday, bolstered by reports that the $700-billion financial market rescue plan appears ready for approval through government channels. Optimism that quick passage of a rescue deal could free up clogged credit lines and spur economic recovery helped investors look right past a spate of dreadful economic reports that came out today. The Russell 2000 (NYSE:IWM) closed up 7.97, or 1.14%, at 705.74. The Russell is now down 7.8% for the year, compared with a loss of 16.9% for the Dow and 17.6% for the S&P 500.

Right now, the market appears to be of a one-track mind, with the immediate hopes rising and falling with the momentum of the Paulson Plan. This afternoon, key Senators said that the plan was progressing nicely, with Senator Chris Dodd, who is chairman of the Senate Banking Committee, saying that a “fundamental agreement” was in place. Meanwhile, Bob Bennett, a Republican senator from Utah, said “I expect we will have a plan that can pass the House, pass the Senate, be signed by the President and bring a sense of certainty to this crisis that is still roiling in the market.”

“Certainty” or the lack thereof clearly is the key. When it appeared Wednesday that political wrangling in an election year over rescue plan details could stall progress on a quick passage, the market made no bones about recoiling from those concerns. Conversely, when the stock market rallied today on hopes the bill could fly through the lawmaking process, investors made another statement by buying up stocks even in the face of slumping economic reports.

Speaking of those economic numbers, the market received bearish data on durable goods, a bearish surprise on weekly claims and yet another bearish report on new home sales. Usually, two out of three would be really bad for this trio, but with all the attention focused on the rescue plan, the market skated right by this terrible trifecta seemingly without worry. For the record, durable goods came in at minus 4.5%, well below the forecast for a dip of 1.9% (and last month was revised downward as well). Meanwhile, weekly unemployment claims shot to 493,000, compared with the consensus forecast of 450,000. Even if the report was “goosed” by . . .

Questor Pharmaceuticals Inc. (Nasdaq:QCOR) and Transmeta Corp. (Nasdaq:TMTA) are the new 52-week highs among small caps.

Here are the new 52-week highs among small caps:

Shares of Transmeta Corp. (Nasdaq:TMTA) are leaping today after the licensor of computing, microprocessor, and semiconductor technologies said that it has initiated a process to seek a potential sale of the company, with the assistance of its independent financial advisor Piper Jaffray.

Shares gained 20%, or $2.71, to $16.21 midday. For detailed price information and news stories on Transmeta, click TMTA.

Small caps remain in the green near their intra-day highs mid-session, snapping a three day losing streak, as hopes that lawmakers are near agreement on the $700 billion bailout plan cheered investors.

At 12:40 p.m. ET. the Russell 2000 (NYSE:IWM) was up 12.70, or 1.82%, to 710.46.

Investors are sending stocks higher today, as passage of the bailout plan looks more likely. President Bush addressed the nation on Wednesday night in an attempt to rally national support for the plan and called a meeting today with Congressional leaders. The administration and the republicans have conceded to democrats’ amendments surrounding caps on executive compensation and judges’ ability to change the value of the toxic mortgages. Still, issues remain on the table — most notably how to stagger the cost of the plan. Passage of the plan would help thaw the frozen credit markets and enable banks to value assets tied to mortgages.

“Despite the increasingly testy exchanges in Congress, I still assume that some close approximation of the plan (with amendments) as currently being discussed will be agreed and become law next week,” Don Straszheim, vice chairman of investment bank Roth Capital, said in an email. “If this effort would come completely unraveled and stalled out, not impossible, my assumption is we would see a financial sector meltdown almost immediately of monumental proportions. Enough people seem to hold similar views that the ‘failure-to-pass’ outcome seems implausible.  It really is an insurance policy given the state of expectations at present.” 

Though the two day testimony for the $700 billion financial bailout plan is complete, Federal Reserve Chairman Ben Bernanke and Treasury Secretary Henry Paulson will remain on Capitol Hill to testify before the House Committee on financial services on the government bailout of mortgage giants Fannie Mae (NYSE:FNM) and Freddie Mac (NYSE:FRE).

While equity markets were higher, treasuries are saying otherwise. Treasuries continued to see yields of unprecedented lows, in a sign that investors demand next to nothing for a safe haven for their short-term cash. The one and three-month Treasury bill yields were both negative at minus 0.38% and minus 0.65% respectively. However, the 2-year and the 10-year were both lower, as their yields were higher midday at 2.1% and 3.8% respectively. (Prices move inversely to yields.)...

Columbia Bancorp (Nasdaq:CBBO), ARYx Therapeutics Inc. (Nasdaq:ARYX) and Transmeta Corp. (Nasdaq:TMTA) are among the biggest percentage gainers in Thursday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Silicon Graphics Inc. (Nasdaq:SGIC), Thomas Weisel Partners Group Inc. (Nasdaq:TWPG), BancTrust Financial Group Inc. (Nasdaq:BTFG), Guaranty Bancorp Ord. (Nasdaq:GBNK), Formula Systems Depository Receipt (Nasdaq:FORTY) and Cypress Bioscience Inc. (Nasdaq:CYPB).

Here are the biggest percentage gainers among small caps:

Transmeta Corp. (Nasdaq:TMTA), Sanderson Farms Inc. (Nasdaq:SAFM) and Solarfun Power Holdings Co Ltd. (Nasdaq:SOLF) are among the most actively traded companies in Thursday's trading among companies with market capitalizations under $1 billion.

Also included among the results: China Sunergy Co Ltd. (Nasdaq:CSUN), American Capital Agency Corp. (Nasdaq:AGNC), Gilat Satellite Networks Ltd. (Nasdaq:GILT), Canadian Solar Inc. (Nasdaq:CSIQ), James River Coal Co. (Nasdaq:JRCC) and Clean Energy Fuels Corp. (Nasdaq:CLNE).

Here are the most actively traded companies among small caps:

Shares of Transmeta Corp. (Nasdaq:TMTA), which develops computing, microprocessor and semiconductor technologies, are slightly higher despite news after the close on Monday that fourth-quarter net loss widened. The Santa Clara, Calif.-based company, which added 26 patents in 2007, reported a loss of $23.9 million, or $1.99 per share for the three months ended Dec. 31, 2007, compared with a loss of $12.7 million, or $1.24 per share, a year earlier.

However, Transmeta also said it has resolved a patent dispute with chip maker Intel Corp. (Nasdaq:INTC) and will receive a total of $250 million over the next five years.

At 3:55 p.m. ET, the stock had added $0.61, or 5%, to $13.93. For detailed price information and recent news stories about Insulet, click TMTA.

Qiao Xing Universal Telephone, Inc. (Nasdaq: XING), Sierra Wireless, Inc. (Nasdaq: SWIR) and Transmeta Corp. (Nasdaq: TMTA) are among the most actively traded companies in Friday pre-market trading among those with market capitalizations under $750 million:

The Russell 2000 (NYSE: IWM) led the way down as the major U.S. indices fell on news of Merrill Lynch’s third-quarter loss and a sharp drop in sales of existing U.S. homes. The small-cap index lost 7.68 points, or 0.94%, to 810.85. The Dow Jones Industrial Average (INDU) let go 0.98 points, or 0.01%, to 13,675.25.

On a year-to-date basis, the Russell 2000 has increased 2.98%, while the Dow has added 9.63% and the S&P 500 has advanced 7.01%.

Small-cap futures were pointing lower and stocks fell out of the gate on news that Merrill Lynch & Co Inc. (NYSE: MER) suffered its first quarterly loss in six years due to $7.9 billion in write-downs.

The world’s largest brokerage house reported a third-quarter net loss of $2.24 billion, or $2.82 per share, below its previous forecast and analysts’ projections. Merrill Lynch blamed the dismal result on being overly exposed to securities backed by subprime mortgages.

The news came as a nasty reminder of the far-reaching effects of the subprime meltdown, which came about as a result of the ongoing slump in the U.S. housing sector. Many mortgage lenders nationwide went bankrupt in the past months following a wave of foreclosures by cash-strapped homeowners.

And the housing sector continues to agonize, at least according to numbers released today by the National Association of Realtors.

The trade association reported that sales of existing U.S. homes fell 8% in September to an annual pace of 5.04 million. That’s the lowest level since the measure was introduced in 1999. The pace of sales in August was a downwardly revised 5.48 million.

Transmeta Corp. (Nasdaq: TMTA), Appliance Recycling Centers of America (Nasdaq: ARCI) and Image Sensing Systems, Inc. (Nasdaq: ISNS) are among the biggest percentage gainers in Wednesday's trading among companies with market capitalizations under $750 million.

Here are today's biggest percentage gainers:

The Russell 2000 (NYSE: IWM) is posting steeper losses this afternoon, with the other major U.S. indices also in negative territory. At 2:00 p.m. ET, the small-cap index had lost 18.77 points, or 2.29%, to 799.76. The Dow Jones Industrial Average (INDU) was down 152.42 points, or 1.11%, to 13,523.81.

Small and large cap stocks are drowning in a sea of red following more negative news about the state of the U.S. housing sector and a nasty reminder of the far-reaching effects of the subprime mortgage meltdown on the financial sector.

Sales of existing U.S. homes fell 8% in September to an annual pace of 5.04 million, according to the National Association of Realtors. That’s the lowest level since the Washington, D.C.-based trade association started keeping tabs in 1999 and a sign that the credit squeeze is sapping demand. The pace of sales in August was 5.48 million.

The median price of an existing home was $211,700 in September, a drop of 4.2% from a year earlier.

The housing sector started to sag in the second half of 2006, leading to a wave of foreclosures and causing a mess in the subprime mortgage sector.

Transmeta Corp. (Nasdaq: TMTA) said today it reached an agreement with Intel to settle all claims between the two companies and license Transmeta’s patent portfolio to Intel for use in current and future Intel products.

The settlement dismisses pending patent litigation between Transmeta and Intel for a mutual general release of all claims of any type between the two. The developer and licenser of computing, microprocessor and semiconductor technologies sued Intel alleging that Intel infringed on Transmeta's patents by making and selling a variety of microprocessor products, including Intel's Pentium III, Pentium 4, Pentium M, Core and Core 2 product lines.

The two companies also struck a deal that gives Intel a perpetual non-exclusive license to all Transmeta patents and patent applications. The license includes any patent rights later acquired by Transmeta, or that may be filed during the next 10 years.

Transmeta will also transfer technology and grant Intel a non-exclusive license to its LongRun and LongRun2 technologies as well as future improvements.

Additionally, under the agreement, Intel has agreed not to sue Transmeta for the development and licensing to third parties of Transmeta’s LongRun and LongRun2 technologies.

Intel will make an initial $150 million payment to Transmeta, as well as pay Transmeta an annual license fee of $20 million for each year of the next five years.

Shares of Transmeta (TMTA) rocketed 219.62%, or $9.18, to $13.36 at 10:56 a.m. ET. Shares of Transmeta have been trading in the range of $4.10 to $26 for the past 52 weeks.

The Russell 2000 (NYSE: IWM) is falling following news of a quarterly loss at Merrill Lynch and a decline in existing home sales.

At 10:55 a.m. ET, the small-cap index had lost 18.28 points, or 2.23%, to 800.25. The Dow Jones Industrial Average (INDU) was down 137.63 points, or 1.01%, to 13,538.60.

New York-based Merrill Lynch & Co Inc. (NYSE: MER) announced before the opening that it suffered its first quarterly loss in six years due to $7.9 billion in write-downs, primarily due to bets made on mortgages and leveraged loans.

Merrill Lynch reported a third-quarter net loss of $2.24 billion, or $2.82 per share, far worse than its forecast on Oct. 5 of a loss of up to $0.50 per share. Wall Street was expecting a loss of $0.45 per share.

That’s a sign that the contagion from the meltdown in the subprime mortgage sector remains active and capable of spreading shockwaves through the financial system. Chairman and CEO Stan O’Neal admitted that Merrill Lynch took a hit because it was too exposed to subprime, according to news reports.

Contributing to the bearish mood is news that U.S. sales of existing homes fell 8% in September, according to the National Association of Realtors. That’s an annual pace of 5.04 million, the lowest since NAR began keeping statistics in 1999.

Transmeta Corp. (Nasdaq: TMTA) is offering to sell $12.8 million worth of securities to institutional investors, the developer of microprocessor and semiconductor technologies announced before the start of trading.

The securities offered include up to two million shares of common stock and warrants to purchase up to one million shares of Transmeta common stock, the Santa Clara, Calif.-based company said. The offering is scheduled to close on or about Sept. 26.

Transmeta said that it plans to use the proceeds to boost its working capital and pay for operations.

At 1:41 p.m. ET, shares of Transmeta (TMTA) were down $1.35, or 18%, to $6.20.

Transmeta Corp. (Nasdaq: TMTA), a developer and licenser of computing, microprocessor and semiconductor technologies, this morning announced that it will sell securities to selected institutional investors for an aggregate price of $12.8 million.

The securities in the offering include up to two million shares of Transmeta common stock and warrants to purchase up to one million shares of Transmeta common stock, which securities are being offered in ‘units’ at a price of $6.40 per unit.

Transmeta said it intends to use the net proceeds from the offering to meet its working capital requirements and fund its operations.

The offering is expected to close on or about Sept. 26, 2007.

Shares of Transmeta (TMTA) were at $7.55 just out of the gate.